GARDNER LEWIS ASSET MANAGEMENT L P
Position in TERN — Terns Pharmaceuticals, Inc.
CIK 941560
CHADDS FORD, PA
Position in TERN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$2,636,000
New position
Shares Held
50,000
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026GARDNER LEWIS ASSET MANAGEMENT L P holds $45,694,110 across 5 Biotechnology names. TERN ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FOLD |
AMICUS THERAPEUTICS, INC.
|
1,414,748 | $20,457,256 | |
| 2 | ACLX |
Arcellx, Inc.
|
123,197 | $14,145,479 | |
| 3 | APLS |
Apellis Pharmaceuticals, Inc.
|
165,000 | $6,637,950 | |
| 4 | TERN |
Terns Pharmaceuticals, Inc.
This page
|
50,000 | $2,636,000 | |
| 5 | DAWN |
Day One Biopharmaceuticals, Inc.
|
84,768 | $1,817,425 |
All Filings in TERN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,636,000 | 50,000 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||